Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol with or without LiDCO monitoring in robotic pelvic fracture surgery
ChiCTR2300069786Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Mar 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and propofol in pelvic fracture (3 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: BIS values, Invasive blood pressure and 7 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
pelvic fracture
Beyond the preview
Go deeper on ChiCTR2300069786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069786.